Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress

T. Kato; H. Satake; K. Oba; Y. Kagawa; H. Yasui; M. Nakamura; T. Watanabe; T. Matsumoto; K. Hirata; K. Muro; Y. Komatsu; T. Yoshino; K. Yamazaki; H. Mishima; M. Kotaka; A. Tsuji; Y. Kakeji; E. Oki; N. Nagata; J. Sakamoto

doi:10.1093/annonc/mdy151.293

Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress

T. Kato, H. Satake, K. Oba, Y. Kagawa, H. Yasui, M. Nakamura, T. Watanabe, T. Matsumoto, K. Hirata, K. Muro, Y. Komatsu, T. Yoshino, K. Yamazaki, H. Mishima, M. Kotaka, A. Tsuji, Y. Kakeji, E. Oki, N. Nagata, J. Sakamoto

Gastrointestinal Surgery (2)

Research output: Contribution to journal › Article › peer-review

27 Citations (Scopus)

Original language	English
Pages (from-to)	v83
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy151.293
Publication status	Published - Jun 1 2018

All Science Journal Classification (ASJC) codes

Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdy151.293

Cite this

Kato, T., Satake, H., Oba, K., Kagawa, Y., Yasui, H., Nakamura, M., Watanabe, T., Matsumoto, T., Hirata, K., Muro, K., Komatsu, Y., Yoshino, T., Yamazaki, K., Mishima, H., Kotaka, M., Tsuji, A., Kakeji, Y., Oki, E., Nagata, N., & Sakamoto, J. (2018). Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. Annals of oncology : official journal of the European Society for Medical Oncology, 29, v83. https://doi.org/10.1093/annonc/mdy151.293

Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. / Kato, T.; Satake, H.; Oba, K. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.06.2018, p. v83.

Research output: Contribution to journal › Article › peer-review

Kato, T, Satake, H, Oba, K, Kagawa, Y, Yasui, H, Nakamura, M, Watanabe, T, Matsumoto, T, Hirata, K, Muro, K, Komatsu, Y, Yoshino, T, Yamazaki, K, Mishima, H, Kotaka, M, Tsuji, A, Kakeji, Y, Oki, E, Nagata, N & Sakamoto, J 2018, 'Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. v83. https://doi.org/10.1093/annonc/mdy151.293

Kato T, Satake H, Oba K, Kagawa Y, Yasui H, Nakamura M et al. Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Jun 1;29:v83. doi: 10.1093/annonc/mdy151.293

@article{a53c3b583f12493f8bef15bb47f15606,

title = "Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress",

author = "T. Kato and H. Satake and K. Oba and Y. Kagawa and H. Yasui and M. Nakamura and T. Watanabe and T. Matsumoto and K. Hirata and K. Muro and Y. Komatsu and T. Yoshino and K. Yamazaki and H. Mishima and M. Kotaka and A. Tsuji and Y. Kakeji and E. Oki and N. Nagata and J. Sakamoto",

year = "2018",

month = jun,

day = "1",

doi = "10.1093/annonc/mdy151.293",

language = "English",

volume = "29",

pages = "v83",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress

AU - Kato, T.

AU - Satake, H.

AU - Oba, K.

AU - Kagawa, Y.

AU - Yasui, H.

AU - Nakamura, M.

AU - Watanabe, T.

AU - Matsumoto, T.

AU - Hirata, K.

AU - Muro, K.

AU - Komatsu, Y.

AU - Yoshino, T.

AU - Yamazaki, K.

AU - Mishima, H.

AU - Kotaka, M.

AU - Tsuji, A.

AU - Kakeji, Y.

AU - Oki, E.

AU - Nagata, N.

AU - Sakamoto, J.

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85081536687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081536687&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy151.293

DO - 10.1093/annonc/mdy151.293

M3 - Article

C2 - 32177280

SN - 0923-7534

VL - 29

SP - v83

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this